TKIs and immunotherapy hold promise for alveolar soft part sarcomaOctober 23, 2018Sarcoma & GISTImmuno-oncology
Checkpoint inhibitor seems safe and effective for patients with HIVOctober 23, 2018Immuno-oncologyMelanomaLung Cancer
Checkpoint inhibitor/TKI combo improves PFS of RCC over sunitinibOctober 22, 2018Renal Cell CarcinomaGenitourinary CancerImmuno-oncology
Kymriah appears cost effective in analysisOctober 17, 2018Immuno-oncologyPediatricsPractice Management
Researchers consider R/R ALL drugs in the first-line settingOctober 17, 2018Leukemia, Myelodysplasia, TransplantationImmuno-oncology
Ibrutinib plus obinutuzumab gets priority review in CLL/SLLOctober 17, 2018Leukemia, Myelodysplasia, TransplantationImmuno-oncology
DETERRED trial: Concurrent atezolizumab, CRT shows promise in LA-NSCLCOctober 15, 2018Lung CancerImmuno-oncology
Epacadostat plus pembrolizumab shows promise in advanced solid tumorsOctober 5, 2018Immuno-oncologyMelanomaRenal Cell CarcinomaLung CancerHead & Neck/Thyroid CancersGynecologic Cancer
B-cell maturation antigen targeted in myeloma trialsOctober 2, 2018Immuno-oncologyLymphoma & Plasma Cell Disorders
IMpower133: Atezolizumab plus standard chemotherapy boosted survival in ES-SCLCOctober 2, 2018Lung CancerImmuno-oncology
Checkpoint inhibitor linked to antiphospholipid syndrome in melanoma patientOctober 2, 2018Immuno-oncologyMelanomaPatient & Survivor Care
First reported case of induced resistance to tisagenlecleucelOctober 1, 2018Leukemia, Myelodysplasia, TransplantationImmuno-oncology
Researchers share Nobel Prize for cancer immunotherapy discoveriesOctober 1, 2018Immuno-oncologyMixed Topics
